Contineum Therapeutics, Inc. Class A Stock (CTNM)
Track Contineum Therapeutics, Inc. Class A stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
CTNM
Contineum Therapeutics, Inc. Class A
healthcare
$13.40
▲ +9.94 (+284.00%) past year
Market Cap
$512.19M
P/E Ratio
—
1Y Return
+284.00%
EPS (TTM)
-$1.95
Read the latest TheStreet Pro articles mentioning Contineum Therapeutics, Inc. Class A, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning CTNM yet.
Daily Diary Mentions
0 mentionsNo diary mentions for CTNM yet.